Skip to main content
logo
TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.7865
+0.0363 (4.84%)
Aug 28, 2026, 7:56 AM EDT - Market open

TScan Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-117.71-129.77-127.5-89.22-66.22-48.63
Depreciation & Amortization
2.882.874.115.365.143.33
Loss (Gain) From Sale of Assets
0.1-----
Loss (Gain) From Sale of Investments
-0.35-2.41-3.9-1.07--
Stock-Based Compensation
9.8411.719.555.214.552.52
Other Operating Activities
0.480.461.860.760.26-
Change in Accounts Payable
-1.25-3.011.99-0.050.530.01
Change in Unearned Revenue
-7.11-10.33-2.8211.89-9.03-6.54
Change in Other Net Operating Assets
-3.17-4.845.885.77-1.730.63
Operating Cash Flow
-116.28-135.32-110.82-61.36-66.5-48.68
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-2.16-4.41-3.83-3.15-4.23-9.94
Investment in Securities
49113.78-48.79-57.61--
Investing Cash Flow
46.87109.37-52.61-60.76-4.23-9.94

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--32.46-29.35-
Long-Term Debt Repaid
---17.14---
Net Debt Issued (Repaid)
--15.31-29.35-
Issuance of Common Stock
0.170.2635.1843.130.3389.94
Other Financing Activities
--0.6158.2792.32-0.32-
Financing Cash Flow
0.17-0.34208.77135.4429.36189.67

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-69.24-26.2845.3313.33-41.37131.05

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-118.44-139.73-114.65-64.5-70.73-58.62
Free Cash Flow Growth
------
Free Cash Flow Margin
-1665.57%-1353.28%-4071.27%-306.45%-522.56%-578.03%
Free Cash Flow Per Share
-1.75-2.46-2.03-1.35-2.94-5.03
Levered Free Cash Flow
-79.92-97.25-68.97-41.83-42.84-33.43
Unlevered Free Cash Flow
-78.18-95.52-66.69-39.48-42.1-33.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
2.312.312.8830.66-
Change in Working Capital
-11.53-18.185.0517.61-10.23-5.9
SEC Filings: 10-K · 10-Q